endocrinologist semaglutide 👩🌸 GLP-1 drugs and PCOS: More than just weight loss!, PCOS is not just a gynecological disorder—it is a metabolic and hormonal condition, with insulin resistance at its core in many women., 🧠 When Considering Semaglutide in the New

In 2022, Medicare gross total spending reached $5.7 billion on Ozempic (semaglutide), Rybelsus (semaglutide), and Mounjaro (tirzepatide), all of which it covered for diabetes that year, according to just-released Medicare drug spending data

And so that's a very good way to get started

Note: indexed curves are used to compare medium-term scenario trajectories when full absolute volumes are not publicly disclosed

In a person without diabetes, the process of eating signals the brain and small intestines to release GLP-1 and GIP

In other words, continuing GLP1 for a prolonged period of time will not lead to a diminishing effect on appetite suppression

GLP-1 medications are powerful tools, but they are not magic pills